Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Correlation Between Plasma Levels of RIP3 and Acute Ischemic Stroke with Large-Artery Atherosclerosis

Author(s): Beilei Chen, Jing Hang, Yuanyuan Zhao, Yang Geng, Xiaobo Li, Zhie Gu, Jun Li, Chao Jiang, Luhang Tao and Hailong Yu*

Volume 19, Issue 1, 2022

Published on: 18 March, 2022

Page: [30 - 37] Pages: 8

DOI: 10.2174/1567202619666220214105208

Price: $65

Abstract

Background: Receptor-interacting serine-threonine protein kinase 3 (RIP3) was previously discovered to be an important medium in the occurrence and development of major atherosclerotic cerebral infarction. However, the role of RIP3 in acute ischemic stroke remains unclear.

Objective: This study aimed to explore the correlation between plasma levels of RIP3 and acute ischemic stroke with large-artery atherosclerosis (LAA).

Methods: This prospective study enrolled 116 patients with LAA, 40 healthy controls, and 30 acute ischemic stroke patients with small-artery occlusion. The patients with LAA were divided according to the quartile of plasma levels of RIP3. A logistic regression model was used for comparison. The ROC curve was performed to evaluate the predictive value.

Results: In patients with LAA, the RIP3 levels in patients with poor outcomes as well as neurological deterioration were significantly higher than those with good outcomes (P < 0.001) and without neurological deterioration (P = 0.014). Patients in the highest levels of plasma RIP3 quartile were more likely to have neurological deterioration (OR, 11.07; 95% CI, 1.990-61.582) and poor outcomes (OR, 35.970; 95% CI, 5.392-239.980) compared with the lowest. The optimal cut-off value for neurological deterioration was 1127.75 pg/mL (specificity, 66.7%; sensitivity, 69.2%) and that for poor prognosis was 1181.82 pg/mL (specificity, 89.7%; sensitivity, 62.1%).

Conclusion: Elevated levels of plasma RIP3 were significantly associated with neurological deterioration and poor prognosis in patients with LAA. A significant increase in plasma RIP3 levels can predict neurological deterioration and the poor prognosis of these patients.

Keywords: Receptor-interacting serine-threonine protein kinase 3, acute ischemic stroke, large-artery atherosclerosis, poor prognosis, neurological deterioration, modified Rankin Scale.

« Previous Next »
[1]
Wang W, Jiang B, Sun H, et al. NESS-China Investigators. Prevalence, incidence, and mortality of stroke in china: Results from a nation-wide population-based survey of 480 687 adults. Circulation 2017; 135(8): 759-71.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025250] [PMID: 28052979]
[2]
Wang D, Liu J, Liu M, Lu C, Brainin M, Zhang J. Patterns of stroke between university hospitals and nonuniversity hospitals in mainland china: Prospective multicenter hospital-based registry study. World Neurosurg 2017; 98: 258-65.
[http://dx.doi.org/10.1016/j.wneu.2016.11.006] [PMID: 27838433]
[3]
Wang Z, Li J, Wang C, et al. Gender differences in 1-year clinical characteristics and outcomes after stroke: Results from the China nation-al stroke registry. PLoS One 2013; 8(2), e56459.
[http://dx.doi.org/10.1371/journal.pone.0056459] [PMID: 23418571]
[4]
Zhang Y, Chen X, Gueydan C, Han J. Plasma membrane changes during programmed cell deaths. Cell Res 2018; 28(1): 9-21.
[http://dx.doi.org/10.1038/cr.2017.133] [PMID: 29076500]
[5]
Liu Y, Liu T, Lei T, et al. RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review) Int J Mol Med 2019; 44(3): 771-86.
[http://dx.doi.org/10.3892/ijmm.2019.4244] [PMID: 31198981]
[6]
Kashlov JK, Donev IS, Doneva JG, et al. Serum levels of RIPK3 and troponin I as potential biomarkers for predicting impaired left ven-tricular function in patients with myocardial infarction with ST segment elevation and normal troponin I levels prior percutaneous coro-nary intervention. Biosci Trends 2016; 10(4): 294-9.
[http://dx.doi.org/10.5582/bst.2016.01077] [PMID: 27431004]
[7]
Hu XM, Chen X, Pang HY, et al. Plasma levels of receptor interacting protein kinase-3 correlated with coronary artery disease. Chin Med J (Engl) 2019; 132(12): 1400-05.
[http://dx.doi.org/10.1097/CM9.0000000000000225] [PMID: 31205096]
[8]
Xu X, Chua KW, Chua CC, Liu CF, Hamdy RC, Chua BH. Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain Res 2010; 1355: 189-94.
[http://dx.doi.org/10.1016/j.brainres.2010.07.080] [PMID: 20682300]
[9]
Hartwig H, Silvestre-Roig C, Hendrikse J, et al. Atherosclerotic plaque destabilization in mice: A comparative study. PLoS One 2015; 10(10), e0141019.
[http://dx.doi.org/10.1371/journal.pone.0141019] [PMID: 26492161]
[10]
Silvestre-Roig C, de Winther MP, Weber C, Daemen MJ, Lutgens E, Soehnlein O. Atherosclerotic plaque destabilization: Mechanisms, models, and therapeutic strategies. Circ Res 2014; 114(1): 214-26.
[http://dx.doi.org/10.1161/CIRCRESAHA.114.302355] [PMID: 24385514]
[11]
Zhang Z, Liu LJ, Zhang C, Yu YP. Association between interleukin-1 gene single nucleotide polymorphisms and ischemic stroke classi-fied by TOAST criteria in the han population of northern China. BioMed Res Int 2013; 2013, 961039.
[http://dx.doi.org/10.1155/2013/961039] [PMID: 24063019]
[12]
Zhang X, Zhang W, Wu X, et al. Prognostic significance of plasma CLEC-2 (C-Type Lectin-Like Receptor 2) in patients with acute is-chemic stroke. Stroke 2018; 50(1), A118022563.
[PMID: 30580704]
[13]
Yang Y, Ma J, Chen Y, Wu M. Nucleocytoplasmic shuttling of receptor-interacting protein 3 (RIP3): Identification of novel nuclear export and import signals in RIP3. J Biol Chem 2004; 279(37): 38820-9.
[http://dx.doi.org/10.1074/jbc.M401663200] [PMID: 15208320]
[14]
Zhang Y, Zhang J, Yan R, et al. Receptor-interacting protein kinase 3 promotes platelet activation and thrombosis. Proc Natl Acad Sci USA 2017; 114(11): 2964-9.
[http://dx.doi.org/10.1073/pnas.1610963114] [PMID: 28242694]
[15]
Lin J, Li H, Yang M, et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep 2013; 3(1): 200-10.
[http://dx.doi.org/10.1016/j.celrep.2012.12.012] [PMID: 23333278]
[16]
Zhang DW, Shao J, Lin J, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325(5938): 332-6.
[http://dx.doi.org/10.1126/science.1172308] [PMID: 19498109]
[17]
Li Z, Delaney MK, O’Brien KA, Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010; 30(12): 2341-9.
[http://dx.doi.org/10.1161/ATVBAHA.110.207522] [PMID: 21071698]
[18]
Shen B, Zhao X, O’Brien KA, et al. A directional switch of integrin signalling and a new anti-thrombotic strategy. Nature 2013; 503(7474): 131-5.
[http://dx.doi.org/10.1038/nature12613] [PMID: 24162846]
[19]
Gong H, Shen B, Flevaris P, et al. G protein subunit Galpha13 binds to integrin alphaIIbbeta3 and mediates integrin “outside-in” signaling. Science 2010; 327(5963): 340-3.
[http://dx.doi.org/10.1126/science.1174779] [PMID: 20075254]
[20]
Shen B, Delaney MK, Du X. Inside-out, outside-in, and inside-outside-in: G protein signaling in integrin-mediated cell adhesion, spread-ing, and retraction. Curr Opin Cell Biol 2012; 24(5): 600-6.
[http://dx.doi.org/10.1016/j.ceb.2012.08.011] [PMID: 22980731]

Rights & Permissions Print Cite
Article Metrics
35
1
© 2024 Bentham Science Publishers | Privacy Policy